Literature DB >> 18079309

Dietary L-tyrosine supplementation in nemaline myopathy.

Monique M Ryan1, Catherine Sy, Sian Rudge, Carolyn Ellaway, David Ketteridge, Laurence G Roddick, Susan T Iannaccone, Andrew J Kornberg, Kathryn N North.   

Abstract

Nemaline myopathy is defined by the presence of nemaline bodies, or rods, on muscle biopsy. Facial and bulbar weakness in nemaline myopathy cause chewing and swallowing difficulties, recurrent aspiration, and poor control of oral secretions. This article discusses 5 patients (4 infants and 1 adolescent) with nemaline myopathy who received dietary supplementation with L-tyrosine (250 to 3000 mg/day). All 4 infants were reported to have an initial decrease in sialorrhoea and an increase in energy levels. The adolescent showed improved strength and exercise tolerance. No adverse effects of treatment were observed. Dietary tyrosine supplementation may improve bulbar function, activity levels, and exercise tolerance in nemaline myopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18079309     DOI: 10.1177/0883073807309794

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  14 in total

1.  Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).

Authors:  Nigel G Laing; Danielle E Dye; Carina Wallgren-Pettersson; Gabriele Richard; Nicole Monnier; Suzanne Lillis; Thomas L Winder; Hanns Lochmüller; Claudio Graziano; Stella Mitrani-Rosenbaum; Darren Twomey; John C Sparrow; Alan H Beggs; Kristen J Nowak
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

2.  Consensus statement on standard of care for congenital myopathies.

Authors:  Ching H Wang; James J Dowling; Kathryn North; Mary K Schroth; Thomas Sejersen; Frederic Shapiro; Jonathan Bellini; Hali Weiss; Marc Guillet; Kimberly Amburgey; Susan Apkon; Enrico Bertini; Carsten Bonnemann; Nigel Clarke; Anne M Connolly; Brigitte Estournet-Mathiaud; Dominic Fitzgerald; Julaine M Florence; Richard Gee; Juliana Gurgel-Giannetti; Allan M Glanzman; Brittany Hofmeister; Heinz Jungbluth; Anastassios C Koumbourlis; Nigel G Laing; Marion Main; Leslie A Morrison; Craig Munns; Kristy Rose; Pamela M Schuler; Caroline Sewry; Kari Storhaug; Mariz Vainzof; Nanci Yuan
Journal:  J Child Neurol       Date:  2012-03       Impact factor: 1.987

Review 3.  Congenital myopathies: an update.

Authors:  Jessica R Nance; James J Dowling; Elizabeth M Gibbs; Carsten G Bönnemann
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

4.  Novel autosomal dominant TNNT1 mutation causing nemaline myopathy.

Authors:  Chamindra G Konersman; Fernande Freyermuth; Thomas L Winder; Michael W Lawlor; Clotilde Lagier-Tourenne; Shailendra B Patel
Journal:  Mol Genet Genomic Med       Date:  2017-08-21       Impact factor: 2.183

5.  Testing of therapies in a novel nebulin nemaline myopathy model demonstrate a lack of efficacy.

Authors:  Tamar E Sztal; Emily A McKaige; Caitlin Williams; Viola Oorschot; Georg Ramm; Robert J Bryson-Richardson
Journal:  Acta Neuropathol Commun       Date:  2018-05-30       Impact factor: 7.801

6.  L-tyrosine supplementation does not ameliorate skeletal muscle dysfunction in zebrafish and mouse models of dominant skeletal muscle α-actin nemaline myopathy.

Authors:  Adriana M Messineo; Charlotte Gineste; Tamar E Sztal; Elyshia L McNamara; Christophe Vilmen; Augustin C Ogier; Dorothee Hahne; David Bendahan; Nigel G Laing; Robert J Bryson-Richardson; Julien Gondin; Kristen J Nowak
Journal:  Sci Rep       Date:  2018-07-31       Impact factor: 4.379

Review 7.  Recent advances in understanding congenital myopathies.

Authors:  Gianina Ravenscroft; Robert J Bryson-Richardson; Kristen J Nowak; Nigel G Laing
Journal:  F1000Res       Date:  2018-12-11

Review 8.  Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction.

Authors:  Heinz Jungbluth; Susan Treves; Francesco Zorzato; Anna Sarkozy; Julien Ochala; Caroline Sewry; Rahul Phadke; Mathias Gautel; Francesco Muntoni
Journal:  Nat Rev Neurol       Date:  2018-02-02       Impact factor: 42.937

Review 9.  Sarcomere Dysfunction in Nemaline Myopathy.

Authors:  Josine M de Winter; Coen A C Ottenheijm
Journal:  J Neuromuscul Dis       Date:  2017

Review 10.  Treating pediatric neuromuscular disorders: The future is now.

Authors:  James J Dowling; Hernan D Gonorazky; Ronald D Cohn; Craig Campbell
Journal:  Am J Med Genet A       Date:  2017-09-10       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.